These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6547566)

  • 1. High-dose amsacrine (AMSA) therapy of relapsed and refractory adult acute nonlymphocytic leukemia. A phase II study.
    Cassileth PA; Lyman GH; Bennett JM; Glick JH; Oken MM
    Am J Clin Oncol; 1984 Aug; 7(4):361-3. PubMed ID: 6547566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4'-(9-acridinylamino)methane-sulfon-m-anisidide (m-AMSA) and 5-azacytidine (AZA) in the treatment of relapsed adult acute leukemia.
    Kahn SB; Sklaroff R; Lebedda J; Conroy JF; Bulova S; Brodsky I
    Am J Clin Oncol; 1983 Aug; 6(4):493-502. PubMed ID: 6191561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of AMSA in children with acute leukemia. A Pediatric Oncology Group study.
    Krischer J; Land VJ; Civin CI; Ragab AH; Mahoney DH; Frankel LS
    Cancer; 1984 Jul; 54(2):207-10. PubMed ID: 6586277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amsacrine in refractory acute leukemia.
    Griffin JD; Maguire ME; Mayer RJ
    Cancer Treat Rep; 1985; 69(7-8):787-9. PubMed ID: 3860296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amsacrine (m-AMSA): a new antineoplastic agent. Pharmacology, clinical activity and toxicity.
    Hornedo J; Van Echo DA
    Pharmacotherapy; 1985; 5(2):78-90. PubMed ID: 2582401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combined therapy with AMSA and etoposide (VP 16-213) in refractory acute myeloid leukemia. A phase I study].
    Hiddemann W; Achterrath W; Urbanitz D; Preusser P; Balleisen L; Kirchhof B; Stenzinger W; Büchner T
    Onkologie; 1984 Aug; 7(4):214-6. PubMed ID: 6384864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amsacrine [4'-(9-acridinylamino)-methanesulfon-m-anisidide] (m-AMSA) and 5-azacytidine (AZA) for remission reinduction in patients with relapsed adult acute nonlymphocytic leukemia. An ECOG pilot study. Eastern Cooperative Oncology Group.
    Kahn SB; Spiers A; Knospe WH; Soojian M; Glick JH
    Am J Clin Oncol; 1987 Feb; 10(1):78-81. PubMed ID: 2435142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I study of VP-16 (etoposide) and amsacrine (AMSA) in the treatment of refractory acute leukemia.
    Letendre L; Hinemann V; Hoagland HC; Kovach JS
    Med Pediatr Oncol; 1985; 13(4):232-4. PubMed ID: 3839284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy with amsacrine (AMSA) and cyclocytidine in refractory childhood leukemia: preliminary observations of a phase II study.
    Miller LP; Miller DR; Tan CT
    Cancer Treat Rep; 1983 May; 67(5):439-43. PubMed ID: 6189604
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II trial of amsacrine in patients with hepatoma: a Cancer and Leukemia Group B study.
    Amrein PC; Richards F; Coleman M; Poulin RF; Holland JF; Weinberg V; Perry M
    Cancer Treat Rep; 1984 Jun; 68(6):923-4. PubMed ID: 6329510
    [No Abstract]   [Full Text] [Related]  

  • 11. High-dose cytosine arabinoside and m-AMSA is effective therapy in relapsed acute nonlymphocytic leukemia.
    Hines JD; Oken MM; Mazza JJ; Keller AM; Streeter RR; Glick JH
    J Clin Oncol; 1984 Jun; 2(6):545-9. PubMed ID: 6233399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of acute leukemia in relapse with 4'(9-acridinylamino) methanesulfon-m-anisidide (AMSA) in combination with cytosine arabinoside and thioguanine.
    Arlin ZA; Flomenberg N; Gee TS; Kempin SJ; Dellaquila C; Mertelsmann R; Straus DJ; Young CW; Clarkson BD
    Cancer Clin Trials; 1981; 4(3):317-21. PubMed ID: 6895190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. m-AMSA: phase II trial in advanced lymphoma and leukemia.
    Case DC
    Am J Clin Oncol; 1984 Aug; 7(4):357-60. PubMed ID: 6588746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I and II study of AMSA in childhood tumours.
    Goldman A; Malpas JS
    Cancer Chemother Pharmacol; 1982; 9(1):53-6. PubMed ID: 6958393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMSA--a promising new agent in refractory acute leukemia.
    Lawrence HJ; Ries CA; Reynolds RD; Lewis JP; Koretz MM; Torti FM
    Cancer Treat Rep; 1982 Jul; 66(7):1475-8. PubMed ID: 7046928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute electrocardiographic changes induced by amsacrine.
    Shinar E; Hasin Y
    Cancer Treat Rep; 1984 Sep; 68(9):1169-72. PubMed ID: 6592038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amsacrine alone or in combination with 5-azacytidine and etoposide in refractory or relapsed acute non lymphoblastic leukemia (ANLL).
    Carella AM; Santini G; Martinengo M; Nati S; Giordano D; Congiu A; Cerri R; Damasio E; Risso M; Rossi E
    Haematologica; 1985; 70(1):39-43. PubMed ID: 2408974
    [No Abstract]   [Full Text] [Related]  

  • 18. High-dose AMSA and autologous bone marrow transplantation in relapsed acute leukemia.
    Zander AR; Vellekoop L; Dicke KA; Keating MJ; McCredie KB; Legha SS; Spitzer G; Verma D; Bodey GP
    Cancer Treat Rep; 1982 Nov; 66(11):1991-2. PubMed ID: 6754077
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase II study of 4'-(9-acridinylamino) methanesulfon-m- anisidide (AMSA) in metastatic melanoma.
    Legha SS; Hall SW; Powell KC; Burgess MA; Benjamin RS; Gutterman JU; Bodey GP
    Cancer Clin Trials; 1980; 3(2):111-4. PubMed ID: 6893573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4'-(9-Acridinylamino) methanesulfon-m-anisidide (AMSA): a new drug effective in the treatment of adult acute leukemia.
    Legha SS; Keating MJ; Zander AR; McCredie KB; Bodey GP; Freireich EJ
    Ann Intern Med; 1980 Jul; 93(1):17-21. PubMed ID: 6930826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.